Front-line treatment for relapsing remitting multiple sclerosis, demyelinating disorder and secondary progressive MS.
▪︎ Interferon beta 1a european standard.
▪︎ Launched in Argentina in 2005.
▪︎ Pharmacovigilance robust program
STRENGTHS:
Each pre-filled syringe contains 22 mcg (6 mIU) or 44 mcg (12 mIU) of Interferon beta 1a within 0.5 ml. of solution.
FORMULATIONS:
Each package contains 12 single dose pre-filled syringes.
The material on this website is oriented to healthcare professionals only. It aims to provide information on how to use these medications efficiently, and to spread the knowledge of these products. This information does not substitute medical diagnosis, advice and indication. Biosidus recommends asking a doctor first.
The texts referring to our prescription drugs abide by the National Administration of Drugs, Foods and Medical Devices (ANMAT) in the Argentine Republic approved guidelines.